TuHURA BIOSCIENCES, INC./NV Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
TuHURA BIOSCIENCES, INC./NV (HURA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $33.17 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-31
- TuHURA BIOSCIENCES, INC./NV effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $33.17K.
- TuHURA BIOSCIENCES, INC./NV effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was -$7.00K.
- TuHURA BIOSCIENCES, INC./NV effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $16.10M.
- TuHURA BIOSCIENCES, INC./NV effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $13.00K, a 93.37% decline from fiscal 2022.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|---|
| 2025-12-31 | $33.17K 10-K · filed 2026-03-31 | |
| 2024-06-30 | -$7.00K 10-K · filed 2024-10-07 | |
| 2023-12-31 | $16.10M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $13.00K 10-K · filed 2024-10-07 | |
| 2022-06-30 | $196.00K 10-K · filed 2023-09-18 | |
| 2020-06-30 | $322.69K 10-K · filed 2020-09-18 | |
| 2019-06-30 | $106.32K 10-K · filed 2020-09-18 | |
| 2018-06-30 | $75.42K 10-K · filed 2019-09-09 | |
| 2017-06-30 | -$62.96K 8-K · filed 2019-06-03 | |
| 2016-06-30 | $34.12K 10-K · filed 2017-09-27 | |
| 2015-06-30 | -$4.78K 10-K · filed 2016-09-13 | |
| 2014-06-30 | -$8.71K 10-K · filed 2014-08-28 | -$8.71K 10-K · filed 2015-11-16 |
| 2012-12-31 | $13.09K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |